Macquarie Group LTD Ocular Therapeutix, Inc Transaction History
Macquarie Group LTD
- $80.3 Billion
- Q1 2025
A detailed history of Macquarie Group LTD transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Macquarie Group LTD holds 244,984 shares of OCUL stock, worth $2.96 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
244,984
Previous 10,548
2222.56%
Holding current value
$2.96 Million
Previous $90,000
1894.44%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding OCUL
# of Institutions
205Shares Held
135MCall Options Held
426KPut Options Held
119K-
Deep Track Capital, LP Greenwich, CT14.3MShares$173 Million3.66% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$168 Million98.53% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$154 Million22.59% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$139 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.36MShares$101 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $930M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...